Kun-Chun Chiang Selected Research

hydroxide ion

7/2018	MART-10, a 1α,25(OH)2D3 Analog, Potently Represses Metastasis of ER+ Breast Cancer Cells with VEGF-A Overexpression.
11/2017	1α,25(OH)2D3 Analog, MART-10, Inhibits Neuroendocrine Tumor Cell Metastasis After VEGF-A Stimulation.
1/2017	MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma.
8/2016	25(OH)D Is Effective to Repress Human Cholangiocarcinoma Cell Growth through the Conversion of 25(OH)D to 1α,25(OH)₂D₃.
7/2016	1α,25(OH)2D3 Analog, MART-10, Inhibits Neuroendocrine Tumor Cell Growth Through Induction of G0/G1 Cell-cycle Arrest and Apoptosis.
4/2016	The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential.
1/2016	MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro.
1/2016	MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells.
12/2015	MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential.
11/2015	Hepatocellular carcinoma cells express 25(OH)D-1α-hydroxylase and are able to convert 25(OH)D to 1α,25(OH)₂D, leading to the 25(OH)D-induced growth inhibition.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kun-Chun Chiang Research Topics

Disease

46	Neoplasms (Cancer) 01/2019 - 04/2006
16	Cholangiocarcinoma 01/2019 - 01/2013
14	Neoplasm Metastasis (Metastasis) 07/2018 - 07/2012
11	Hypercalcemia (Milk Alkali Syndrome) 01/2016 - 07/2009
10	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 09/2018 - 04/2006
8	Breast Neoplasms (Breast Cancer) 07/2018 - 01/2012
5	Carcinoma (Carcinomatosis) 01/2020 - 01/2014
5	Wounds and Injuries (Trauma) 05/2017 - 06/2013
4	Inflammation (Inflammations) 03/2020 - 01/2011
4	Hepatocellular Carcinoma (Hepatoma) 03/2020 - 09/2009
4	Liver Neoplasms (Liver Cancer) 09/2017 - 09/2009
4	Pancreatic Neoplasms (Pancreatic Cancer) 11/2014 - 07/2009
3	Margins of Excision 11/2018 - 01/2014
3	Hemorrhagic Shock 05/2017 - 06/2013
3	Hemorrhage 05/2017 - 06/2013
3	Squamous Cell Carcinoma of Head and Neck 08/2016 - 11/2013
2	Carcinogenesis 01/2019 - 05/2016
2	Papillary Thyroid Cancer 03/2018 - 05/2017
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2017 - 07/2016
2	Body Weight (Weight, Body) 09/2017 - 04/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016 - 11/2013
2	Chronic Kidney Failure (Chronic Renal Failure) 04/2015 - 08/2013
2	Shock 01/2015 - 06/2013
2	Hand-Foot Syndrome 10/2014 - 09/2014
2	Edema (Dropsy) 09/2014 - 06/2013
2	Prostatic Neoplasms (Prostate Cancer) 07/2014 - 09/2009
2	Pain (Aches) 05/2014 - 01/2007
1	Pancreatitis 01/2019
1	Aggressive Fibromatosis (Desmoid) 07/2018
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 05/2018
1	Choledocholithiasis 01/2018
1	Thyroid Neoplasms (Thyroid Cancer) 09/2017

Drug/Important Bio-Agent (IBA)

20	hydroxide ionIBA 07/2018 - 07/2009
19	Vitamin D FDA LinkGeneric 01/2017 - 07/2009
15	19- nor- 2- (3- hydroxypropyl)- 1,25- dihydroxyvitamin D3IBA 07/2018 - 09/2009
9	Imatinib Mesylate (Gleevec)FDA Link 03/2017 - 04/2006
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2015
4	Caspase 3 (Caspase-3)IBA 05/2017 - 12/2011
4	Sunitinib (Sutent)FDA Link 03/2017 - 09/2014
4	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2017 - 09/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 11/2017
3	AntigensIBA 11/2018 - 05/2012
3	CarbohydratesIBA 11/2018 - 05/2012
3	Estrogen ReceptorsIBA 07/2018 - 01/2012
3	EnzymesIBA 09/2017 - 11/2014
3	salicylhydroxamic acid (SHAM)IBA 05/2017 - 06/2013
2	Heme Oxygenase-1IBA 03/2020 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 03/2020 - 01/2014
2	AntioxidantsIBA 03/2020 - 01/2020
2	Thioacetamide (Thioacetamid)IBA 01/2019 - 08/2013
2	MelatoninIBA 01/2019 - 05/2017
2	Aurora Kinase AIBA 09/2018 - 06/2014
2	Propolis (Bee Bread)IBA 05/2018 - 01/2017
2	caffeic acid phenethyl esterIBA 05/2018 - 01/2017
2	fenbufenIBA 12/2017 - 09/2017
2	BoronIBA 12/2017 - 09/2017
2	Thyroglobulin FDA Link 09/2017 - 05/2017
2	SB 203580IBA 05/2017 - 01/2015
2	Peroxidase (Myeloperoxidase)IBA 05/2017 - 06/2013
2	p38 Mitogen-Activated Protein KinasesIBA 05/2017 - 01/2015
2	MineralsIBA 01/2017 - 01/2016
2	SERPIN-B5 (maspin)IBA 08/2016 - 05/2016
2	Protein Isoforms (Isoforms)IBA 08/2016 - 04/2006
2	Biomarkers (Surrogate Marker)IBA 08/2016 - 11/2014
2	25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA 08/2016 - 11/2015
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 08/2016 - 01/2015
2	TensinsIBA 08/2016 - 01/2015
2	VimentinIBA 05/2016 - 11/2014
2	Cholecalciferol (Vitamin D3)FDA Link 12/2015 - 10/2012
2	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 01/2015 - 06/2013
2	Phosphotransferases (Kinase)IBA 11/2014 - 04/2006
2	Prostate-Specific Antigen (Semenogelase)IBA 07/2014 - 01/2014
2	Antineoplastic Agents (Antineoplastics)IBA 01/2012 - 01/2011
2	paricalcitol (Zemplar)FDA Link 09/2009 - 07/2009
1	Conditioned Culture MediaIBA 01/2019
1	Erythropoietin FDA Link 01/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019
1	InterferonsIBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2018
1	Annexin A5IBA 07/2018
1	130-nm albumin-bound paclitaxelIBA 07/2018
1	Complement System Proteins (Complement)IBA 03/2018
1	regorafenibIBA 12/2017
1	Glucose (Dextrose)FDA LinkGeneric 09/2017
1	HeliumIBA 09/2017
1	IodineIBA 09/2017
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 09/2017
1	Melatonin Receptors (Melatonin Receptor)IBA 05/2017
1	Adenosine Triphosphate (ATP)IBA 05/2017
1	anti-thyroglobulinIBA 05/2017

Therapy/Procedure

14	Therapeutics 09/2018 - 07/2009
7	Radiotherapy 01/2019 - 07/2009
6	Drug Therapy (Chemotherapy) 01/2019 - 07/2009
4	Hepatectomy 09/2018 - 01/2015
4	Laparotomy 05/2017 - 06/2013
3	Resuscitation 05/2017 - 06/2013
2	Boron Neutron Capture Therapy 12/2017 - 09/2017
2	Gastrectomy 04/2015 - 01/2014
1	Cholecystectomy 01/2018
1	Thyroidectomy 05/2017